{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:01:12Z","timestamp":1773694872753,"version":"3.50.1"},"reference-count":25,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>In 2017, the American Academy of Pediatrics introduced a new guideline (2017 Clinical Practice Guideline of the American Academy of Pediatrics [AAP 2017]) to diagnose arterial hypertension (HTN) in children that included revised, lower normative blood pressure (BP) values and cut points for diagnosing high BP in adolescents. We studied the impact of the new AAP 2017 on prevalence of HTN in children with type 1 diabetes mellitus (T1DM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Up to September 2018, 1.4 million office BP measurements in 79,849 children and adolescents (aged 5\u201320 years) with T1DM were documented in the DPV (Diabetes Prospective Follow-up) registry. BP values of the most recent year were aggregated, and BP values of 74,677 patients without antihypertensive medication were analyzed (median age 16 years and diabetes duration 5.3 years, 52.8% boys). BP values were classified according to AAP 2017 and the references of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) (2011) and the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents (fourth report) (2004).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Of the patients, 44.1%, 29.5%, and 26.5% were hypertensive according to AAP 2017, KiGGS, and fourth report, respectively. Differences in prevalence of HTN were strongly age dependent: &amp;lt;10 years, AAP 2017 31.4%, KiGGS 30.7%, fourth report 19.6%; 10 to &amp;lt;15 years, AAP 2017 30.9%, KiGGS 31.2%, fourth report 22.4%; and \u226515 years, AAP 2017 53.2%, KiGGS 28.4%, fourth report 30.0%. Among teenagers \u226515 years, 59.1% of boys and only 46.3% of girls were classified as hypertensive by AAP 2017 but only 21.1%\/26% of boys and 36.7%\/34.4% of girls by KiGGS\/fourth report, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Classification of BP as hypertension depends strongly on the normative data used. Use of AAP 2017 results in a significant increase in HTN in teenagers \u226515 years with T1DM, particularly in boys. AAP 2017 enhances the awareness of elevated BP in children, particularly in patients with increased risk for cardiovascular disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc19-2022","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T01:45:45Z","timestamp":1585619145000},"page":"1311-1318","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":13,"title":["2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-6513","authenticated-orcid":false,"given":"Axel","family":"Dost","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University Hospital Jena, Jena, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bechtold","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Diabetology, Haunersche Kinderklinik, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Fink","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Bonfig","sequence":"additional","affiliation":[{"name":"Pediatrics, Klinikum Wels-Grieskirchen GmbH, Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagobert","family":"Wiemann","sequence":"additional","affiliation":[{"name":"Pediatric Diabetology\/Endocrinology, University Hospital Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Kapellen","sequence":"additional","affiliation":[{"name":"Pediatric Diabetology, University Hospital Leipzig, Leipzig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Witsch","sequence":"additional","affiliation":[{"name":"Pediatric Diabetology, Centre Hospitalier de Luxembourg, Luxembourg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl O.","family":"Schwab","sequence":"additional","affiliation":[{"name":"Pediatrics and Adolescence Medicine, University Hospital Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany"},{"name":"German Center for Diabetes Research (DZD), Neuherberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"2022031300334367800_B1","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents [published correction appears in Pediatrics 2017;140; Pediatrics 2018;142]","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"2022031300334367800_B2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2337\/dc07-0824","article-title":"Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes","volume":"31","author":"Dost","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031300334367800_B3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00246-009-9510-6","article-title":"Synergistic effects of elevated systolic blood pressure and hypercholesterolemia on carotid intima-media thickness in children and adolescents","volume":"30","author":"Krebs","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"2022031300334367800_B4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/pedi.12502","article-title":"Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: impact on diabetic complications","volume":"18","author":"Dost","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"2022031300334367800_B5","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.amjcard.2011.02.319","article-title":"Current status of aggressive blood glucose and blood pressure control in diabetic hypertensive subjects","volume":"107","author":"Chrysant","year":"2011","journal-title":"Am J Cardiol"},{"key":"2022031300334367800_B6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HJH.0b013e3283469976","article-title":"Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients","volume":"29","author":"Reboldi","year":"2011","journal-title":"J Hypertens"},{"key":"2022031300334367800_B7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/pedi.12656","article-title":"Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicenter DPV study on 24 011 patients from Germany, Austria or Luxembourg","volume":"19","author":"Bohn","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2022031300334367800_B8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jch.12743","article-title":"Seasonal variation in blood pressure in 162,135 patients with type 1 or type 2 diabetes mellitus","volume":"18","author":"Hermann","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2022031300334367800_B9","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1542\/peds.2010-1290","article-title":"Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany","volume":"127","author":"Neuhauser","year":"2011","journal-title":"Pediatrics"},{"key":"2022031300334367800_B10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"key":"2022031300334367800_B11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2458-8-196","article-title":"The challenge of comprehensively mapping children\u2019s health in a nation-wide health survey: design of the German KiGGS-Study","volume":"8","author":"Kurth","year":"2008","journal-title":"BMC Public Health"},{"key":"2022031300334367800_B12","doi-asserted-by":"crossref","first-page":"k2357","DOI":"10.1136\/bmj.k2357","article-title":"Impact of 2017 ACC\/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study","volume":"362","author":"Khera","year":"2018","journal-title":"BMJ"},{"key":"2022031300334367800_B13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.118.11673","article-title":"Prevalence of hypertension in children","volume":"73","author":"Bell","year":"2019","journal-title":"Hypertension"},{"key":"2022031300334367800_B14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIR.0000000000000094","article-title":"Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association","volume":"130","author":"Maahs","year":"2014","journal-title":"Circulation"},{"key":"2022031300334367800_B15","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00125-007-0921-8","article-title":"High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study","volume":"51","author":"Margeirsdottir","year":"2008","journal-title":"Diabetologia"},{"key":"2022031300334367800_B16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/dc07-1392","article-title":"Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes: a multicenter longitudinal survey in Germany and Austria","volume":"31","author":"Knerr","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031300334367800_B17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pedi.12083","article-title":"Pulse pressure in children and adolescents with type 1 diabetes mellitus in Germany and Austria","volume":"15","author":"Dost","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"2022031300334367800_B18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-017-0780-8","article-title":"Updated guideline may improve the recognition and diagnosis of hypertension in children and adolescents; review of the 2017 AAP blood pressure clinical practice guideline","volume":"19","author":"Dionne","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"2022031300334367800_B19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.118.11818","article-title":"Out-of-clinic sympathetic activity is increased in patients with masked uncontrolled hypertension","volume":"73","author":"Siddiqui","year":"2019","journal-title":"Hypertension"},{"key":"2022031300334367800_B20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00112-002-0463-6","article-title":"\u00dcbergewicht und Adipositas bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1","volume":"151","author":"Stachow","year":"2003","journal-title":"Monatschr Kinderklinik"},{"key":"2022031300334367800_B21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jpeds.2015.05.046","article-title":"Obesity in youth with type 1 diabetes in Germany, Austria, and the United States","volume":"167","author":"DuBose","year":"2015","journal-title":"J Pediatr"},{"key":"2022031300334367800_B22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bcp.13482","article-title":"Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use","volume":"84","author":"Ahmdizar","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2022031300334367800_B23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamapediatrics.2018.0223","article-title":"Prevalence and severity of high blood pressure among children based on the 2017 American Academy of Pediatrics guidelines","volume":"172","author":"Sharma","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2022031300334367800_B24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.113.001614","article-title":"Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium","volume":"128","author":"Juhola","year":"2013","journal-title":"Circulation"},{"key":"2022031300334367800_B25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamapediatrics.2018.0375","article-title":"What is the prevalence of childhood hypertension?: It depends on the definition","volume":"172","author":"Daniels","year":"2018","journal-title":"JAMA Pediatr"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/6\/1311\/630117\/dc192022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/6\/1311\/630117\/dc192022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:51:16Z","timestamp":1647143476000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/6\/1311\/35682\/2017-American-Academy-of-Pediatrics-Clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,3,30]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-2022","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]}}}